GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Genesystem Co Ltd (XKRX:363250) » Definitions » Change In Other Working Capital

Genesystem Co (XKRX:363250) Change In Other Working Capital : ₩-352.4 Mil (TTM As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Genesystem Co Change In Other Working Capital?

Genesystem Co's Change In Other Working Capital for the quarter that ended in Mar. 2024 was ₩0.0 Mil. It means Genesystem Co's Other Working Capital stayed the same from Dec. 2023 to Mar. 2024 .

Genesystem Co's Change In Other Working Capital for the fiscal year that ended in Dec. 2023 was ₩-352.4 Mil. It means Genesystem Co's Other Working Capital declined by ₩352.4 Mil from Dec. 2022 to Dec. 2023 .


Genesystem Co Change In Other Working Capital Historical Data

The historical data trend for Genesystem Co's Change In Other Working Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genesystem Co Change In Other Working Capital Chart

Genesystem Co Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Change In Other Working Capital
80.97 982.40 -570.03 -824.08 -352.38

Genesystem Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Change In Other Working Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 57.13 -521.93 216.89 -104.47 -

Genesystem Co Change In Other Working Capital Calculation

Change In Other Working Capital is any increase or decrease between periods of other working capital that are not otherwise classified.

Change In Other Working Capital for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-352.4 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Genesystem Co Change In Other Working Capital Related Terms

Thank you for viewing the detailed overview of Genesystem Co's Change In Other Working Capital provided by GuruFocus.com. Please click on the following links to see related term pages.


Genesystem Co (XKRX:363250) Business Description

Traded in Other Exchanges
N/A
Address
200-9, Techno 2-ro, Yuseong-gu, Daejeon, KOR, 34028
Genesystem Co Ltd is a biotech engineering company specializing in molecular testing solutions that target on-site testing needs. It develops and markets state-of-the-art PCR platforms as well as related reagents and biochip products designed to enhance the health of human societies and improve the quality of human life.

Genesystem Co (XKRX:363250) Headlines

No Headlines